Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Legal issues for chem-bioinformatics models.

Duardo-Sanchez A, Gonzalez-Diaz H.

Front Biosci (Elite Ed). 2013 Jan 1;5:361-74. Review.

PMID:
23276995
2.

Current topics on software use in medicinal chemistry: intellectual property, taxes, and regulatory issues.

Duardo-Sánchez A, Patlewicz G, López-Díaz A.

Curr Top Med Chem. 2008;8(18):1666-75.

PMID:
19075773
3.

Patents of bio-active compounds based on computer-aided drug discovery techniques.

Prado-Prado F, Garcia-Mera X, Rodriguez-Borges JE, Concu R, Perez-Montoto LG, Gonzalez-Diaz H, Duardo-Sanchez A.

Front Biosci (Elite Ed). 2013 Jan 1;5:399-407. Review.

PMID:
23276997
4.

From QSAR models of drugs to complex networks: state-of-art review and introduction of new Markov-spectral moments indices.

Riera-Fernández P, Martín-Romalde R, Prado-Prado FJ, Escobar M, Munteanu CR, Concu R, Duardo-Sanchez A, González-Díaz H.

Curr Top Med Chem. 2012;12(8):927-60. Review.

PMID:
22352918
5.

Patenting bioinformatic inventions: emerging trends in the United States.

Hultquist SJ, Harrison R, Yang Y.

Nat Biotechnol. 2002 Jul;20(7):743-4. No abstract available.

PMID:
12089563
6.

Regulatory issues in management of chemicals in OECD member countries.

Kleandrova VV, Speck-Planche A.

Front Biosci (Elite Ed). 2013 Jan 1;5:375-98. Review.

PMID:
23276996
7.

When software isn't for sharing.

Agrawal A.

Curr Biol. 2001 Oct 30;11(21):R848-9. No abstract available.

8.

Bioinformatics -- a patenting view.

Maschio T, Kowalski T.

Trends Biotechnol. 2001 Sep;19(9):334-9.

PMID:
11513996
9.

Theory and reality for software patents: good in concept, not so good in practice.

Wren JD.

Bioinformatics. 2006 Jul 1;22(13):1543-5. No abstract available.

PMID:
16801635
10.

It is time to end the patenting of software.

Quackenbush J, Salzberg SL.

Bioinformatics. 2006 Jun 15;22(12):1416-7. No abstract available.

11.

Protecting innovation in bioinformatics and in-silico biology.

Harrison R.

BioDrugs. 2003;17(4):227-31. Review.

PMID:
12899639
12.

Testing computational toxicology models with phytochemicals.

Valerio LG Jr, Arvidson KB, Busta E, Minnier BL, Kruhlak NL, Benz RD.

Mol Nutr Food Res. 2010 Feb;54(2):186-94. doi: 10.1002/mnfr.200900259.

PMID:
20024931
13.

Predicting drugs and proteins in parasite infections with topological indices of complex networks: theoretical backgrounds, applications, and legal issues.

González-Díaz H, Romaris F, Duardo-Sanchez A, Pérez-Montoto LG, Prado-Prado F, Patlewicz G, Ubeira FM.

Curr Pharm Des. 2010;16(24):2737-64. Review.

PMID:
20642428
14.

Patents versus settling for the soft option.

Carter S.

Med Device Technol. 2004 Mar;15(2):19. No abstract available.

PMID:
15154334
15.

Patent reform, pending.

Kahaner L.

Across Board (NY). 1984 Sep;21(9):36-9. No abstract available.

PMID:
10278269
16.

The Gold Rush of '89.

Counts RW.

J Comput Aided Mol Des. 1989 Sep;3(3):285-6. No abstract available.

PMID:
2585003
17.

Intellectual property law: a primer for scientists.

Brown WM.

Mol Biotechnol. 2003 Mar;23(3):213-24. Review.

PMID:
12665692
18.

Software patents await legal fate.

Ledford H.

Nature. 2014 Mar 27;507(7493):410-1. doi: 10.1038/507410a. No abstract available.

PMID:
24670739
19.

Computational quantum chemistry and adaptive ligand modeling in mechanistic QSAR.

De Benedetti PG, Fanelli F.

Drug Discov Today. 2010 Oct;15(19-20):859-66. doi: 10.1016/j.drudis.2010.08.003. Epub 2010 Aug 13. Review.

PMID:
20709183
20.

Recent developments of the chemistry development kit (CDK) - an open-source java library for chemo- and bioinformatics.

Steinbeck C, Hoppe C, Kuhn S, Floris M, Guha R, Willighagen EL.

Curr Pharm Des. 2006;12(17):2111-20. Review.

Supplemental Content

Support Center